Pacemakers and Implantable Cardioverter-Defibrillators: Essentials for Clinicians

Published on 02/03/2015 by admin

Filed under Cardiovascular

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3471 times

Chapter 21 Pacemakers and Implantable Cardioverter-Defibrillators Essentials for Clinicians

Please go to expertconsult.com for supplemental chapter material.

This chapter provides a brief introduction to a daunting, but important aspect of everyday ECG analysis—electronic cardiac devices: pacemakers and implantable cardioverter-defibrillators (ICDs). Additional material is provided in the online supplement.

Pacemakers: Definitions and Types

A pacemaker consists of two major components: (1) a pulse generator (battery and microcomputer) and (2) one or more electrodes (also called leads). The electrodes can be attached to the skin (in the case of emergency transcutaneous pacing), but more often are attached directly to the inside of the heart (Fig. 21-1).

Pacemakers can be temporary or permanent. Temporary pacing is used when the electrical abnormality is expected to resolve within a relatively short time. Temporary pacing electrodes are inserted transvenously with the generator outside the body. For example, temporary pacing is used in marked bradycardia associated with cardiac surgery, inferior wall myocardial infarction (MI), Lyme disease, or drug toxicity. When normal cardiac electrical function returns, the temporary pacing electrode can be easily removed.

Permanent pacemakers have both the generator and electrode(s), also called leads, implanted inside the body (see Fig. 21-1). Electronic pacemakers are used for three major purposes:

Depending on the indication, pacemakers have from one to three leads. Most often the leads are implanted transvenously (through cephalic or subclavian veins) with the generator unit (consisting of the power supply and a microcomputer) positioned subcutaneously in the anterior shoulder area. In some cases the leads are implanted on the epicardial (outer) surface of the heart, using a surgical approach (for example, to avoid intravascular exposure in patients with high risk of endocarditis).

All contemporary pacemakers are capable of sensing intrinsic electrical activity of the heart and are externally programmable (adjustable) using special computer devices provided by the manufacturers. Pacemakers are usually set to operate in an on-demand mode, providing electronic pacing support only when the patient’s own electrical system fails to generate impulses in a timely fashion. Modern pacemaker batteries last on average between about 8 and 12 years, depending on usage.

Single- and Dual-Chamber Pacemakers

Single-lead (or single-chamber) pacemakers (see Fig. 21-1), as their name indicates, are used to stimulate only one chamber (right atrium or right ventricle). Atrial single-lead pacemakers (with the lead positioned in the right atrium) can be used to treat isolated sinus node dysfunction with normal AV conduction (Fig. 21-2). In the United States, single-lead atrial pacemakers are rarely used. Even patients with isolated sinus node dysfunction usually receive dual-chamber devices because AV conduction abnormalities often develop later as the patient ages.

Ventricular single-lead pacemakers (with the lead positioned in the right ventricle) are primarily used to generate the heartbeat in patients with chronic atrial fibrillation with an excessively slow ventricular response. The atrial fibrillation precludes effective atrial stimulation so that there is no reason to insert an atrial lead (Fig. 21-3).

In dual-chamber pacemakers, electrodes are inserted into both the right atrium and right ventricle (Figs. 21-4 and 21-5). The circuitry is designed to allow for a physiologic delay (normal synchrony) between atrial and ventricular stimulation. This AV delay (interval between the atrial and ventricular pacemaker spikes) is analogous to the PR interval under physiologic conditions.

ECG Morphology of Paced Beats

Paced beats start with a pacing spike—a sharp vertical deflection from the pacemaker stimulus. If the pacing threshold is low, the amplitude of pacing spikes can be very small and they can be easily missed.

A paced P wave demonstrates a pacing spike followed by a P wave (see Fig. 21-2).

A paced QRS beat also starts with a pacing spike, followed by a wide QRS complex (see Figs. 21-3 and 21-6). The wide QRS is due to the fact that activation of the ventricles starts at the tip of the lead and spreads to the other ventricle through slowly conducting myocardium, similar to what occurs with ventricular premature beats (VPBs) or ventricular escape beats. The QRS morphology depends on the lead (electrode) position. The most commonly used ventricular electrode site is the right ventricular apex. Pacing at this location produces a wide QRS (usually resembling an LBBB pattern; see Chapter 7) with a leftward axis (QRS deflections are predominantly negative in leads II, III, and aVF and positive in leads I and aVL).

As with VPBs, the T waves in paced beats normally are discordant—directed opposite to the main QRS direction (see Figs. 21-3 and 21-5). Concordant T wave (i.e., pointing in the same direction as the paced QRS) during ventricular pacing may indicate acute myocardial ischemia (see following discussion).

Ventricular paced beats, similar to VPBs, can also sometimes conduct in a retrograde manner to the atria, producing near simultaneous atrial and ventricular depolarization and contraction (Fig. 21-6). When this occurs repeatedly, atrial contraction against the closed AV valves produces recurrent, sudden increases in jugular (and pulmonary) vein pressures, which may be seen as “cannon” A waves in the neck examination. Of note for clinicians, these abrupt pressure changes, in turn, may activate a vagal reflex and cause severe symptoms (palpitations, pulsation in the neck, dizziness, and blood pressure drop), often referred to as the pacemaker syndrome. Therefore, patients in sinus rhythm with AV block are usually implanted with dual-chamber pacemakers so that ventricular pacing will occur after atrial pacing, maintaining physiologic AV timing (synchrony).

Single-Chamber Pacemaker Programming

As noted, modern pacemakers are programmed in the on-demand mode providing pacing support only when needed. In the case of a single-chamber pacemaker this function is accomplished by specifying the lower rate limit (for example 60 beats/min). The pacemaker constantly monitors the patient’s heart rate in the implanted chamber on a beat to beat basis. Any time the rate drops below the lower rate limit (in the case of 60/min, the critical pause after a spontaneous QRS complex will be >1 sec), the pacemaker will deliver a pacing stimulus (Fig. 21-7). This corresponds to the code: VVI 60.

To simulate the heart rate increase that normally occurs with exertion, pacemakers can now also be programmed in a rate-responsive or adaptive mode. The purpose of this mode is to increase the lower rate limit dynamically, depending on the level of physical activity as detected by a sensor incorporated in the generator unit. For example, one of your patients may have rate-responsive ventricular single-chamber pacemaker programming, referred to as VVIR 60-110, in which the R indicates “rate-responsive” and the second number (110 in this case) represents the upper pacing limit, which is the maximum rate that the device will pace the ventricles in response to its activity sensor.

Dual-Chamber Pacemaker Programming

Dual-chamber pacemakers have two leads (one in the right atrium, one in the right ventricle), each capable of sensing intrinsic electrical activity to determine the need for pacing in each chamber. For “on-demand” dual-chamber pacemakers—the most common types—atrial pacing is determined by the lower rate limit while ventricular pacing is determined by the separately programmed maximum AV delay.

Depending on the atrial rate and the status of intrinsic AV conduction, dual-chamber pacemakers can produce four different combinations of pacing/sensing ECG patterns (Figs. 21-4, 21-7 and 21-8):

This programming corresponds to the code in Table 21-1.

DDD pacing and sensing occur in both chambers (the first and second D). The response to sensing is also dual (D): inhibition if intrinsic activity in the chamber is sensed (A sense, V sense) or triggering V pacing when there is sensing in the A but no AV conduction at maximum AV delay (A sense, V pace). As with single-chamber pacemakers, dual-chamber devices can be programmed in a rate-responsive mode.

DDD and DDDR are the most commonly used pacing modes in dual-chamber pacemakers. Dual-chamber pacemakers can be reprogrammed in a single-chamber mode as well.

On-demand programming has significant advantages, including prolonging battery life and avoiding unnecessary pacing especially in the ventricle. Its downside is the possibility to mistake external electrical signals for the patient’s own electrical activity. This would result in pacemaker inhibition and inappropriate withholding of pacing. Situations like this can occur, for example, with the use of electrosurgical equipment or exposure to strong electromagnetic fields, such as created by magnetic resonance imaging (MRI) machines. In these cases pacemakers can be reprogrammed in asynchronous mode (DOO or VOO) and will provide pacing at the lower rate limit regardless of ambient electrical activity. DOO mode is used in MRI-compatible pacemakers for the duration of the scan.

Clinicians should be familiar with two additional programming features in dual-chamber pacemakers designed to optimize device function during atrial arrhythmias: maximal tracking rate and automatic mode switching.

Biventricular Pacemakers: Cardiac Resynchronization Therapy

Similar to right ventricular pacing, LBBB causes late activation/contraction of the left ventricular lateral wall (ventricular dyssynchrony). Often present in patients with cardiomyopathy and heart failure, LBBB further reduces the effectiveness of ventricular contraction and exacerbates cardiac dysfunction. Restoring appropriate timing of left ventricular lateral wall activation (resynchronization) usually results in improvement in the left ventricular function as well as reverse remodeling of the left ventricle over time with progressive recovery (and sometimes complete normalization) of the left ventricular function.

This positive effect is accomplished by biventricular pacing. In addition to the usual right ventricular pacing lead, another electrode is placed to stimulate the left ventricle. Usually this second lead is advanced transvenously through a branch of the coronary sinus on the posterolateral wall of the left ventricle (Fig. 21-9) because this is the latest activated area with intrinsic LBBB or with right ventricular pacing.

Both ventricles are then paced simultaneously, producing fusion-type QRS complexes (Figs. 21-10 and 21-11) that represent a “hybrid” between those seen with pure right and left ventricular pacing. The QRS morphology can be quite variable depending on the position of the left ventricular electrode, but usually the QRS has prominent R waves in leads V1-V2 (RBBB-type morphology due to posterior left ventricular wall activation from back to front) as well as Q waves in leads I and aVL (left ventricular electrode activating the heart from left to right). The QRS duration during biventricular pacing is usually shorter than with right ventricular pacing or with an intrinsic LBBB.

ECG Diagnosis Related to Paced Rhythms

Ventricular paced rhythms regularize ventricular rate and distort QRS and T wave shapes in a manner similar to LBBB. This makes further analysis of QRS, ST segment, and T wave virtually impossible. However, there are several ECG patterns that should not be missed even in paced rhythms or in ECGs obtained after ventricular pacing.

Cardiac “Memory” T Wave Inversions

Ventricular pacing produces electrical changes in the heart that last a long time after the pacing stops (process called cardiac memory). In patients who are paced intermittently, these changes can be seen in nonpaced beats as T wave inversions in the leads that showed predominantly negative QRS during ventricular pacing (usually precordial and inferior leads) (see Fig. 21-7). These changes look very much like T wave inversions due to myocardial ischemia (Wellens’ syndrome). However, leads I and aVL usually show upright T waves in normally conducted beats after a period of ventricular pacing, although anterior ischemia is often associated with T wave inversions in these leads.

Implantable Cardioverter-Defibrillators

Modern ICD systems resemble pacemakers in appearance, but with slightly larger generators and thicker right ventricular leads (Fig. 21-13). They are both implanted in a similar fashion. ICDs differ from the usual external defibrillation paddles or patches because in ICDs electrical current passes between one or two special coils on the ventricular lead and the generator.

All current ICDs are capable of pacing and can be single-chamber, dual-chamber, or biventricular.

Arrhythmia detection is based primarily on the heart rate and can be programmed in up to several different heart rate zones (for example, slow VT, fast VT, and VF zones at 160, 180, 200 beats/min). Arrhythmia treatments then can be set up separately in each of the zones (Fig. 21-14) as part of automatic “tiered” (ramped) therapy.

ICDs provide two programmable modalities of treatment for ventricular tachyarrhythmias: antitachycardia pacing (ATP) and direct current (DC) shocks. ATP works by pacing the heart faster than the rate of VT. This allows penetration of the signal into the reentrant arrhythmia circuit, “breaking” the reentrant loop and restoring normal rhythm. ATP terminates approximately 50% of ventricular arrhythmias, avoiding the need for ICD shocks. Unlike shock delivery, ATP is completely painless and usually goes unnoticed by the patient.

If ATP fails to convert the arrhythmia, then up to six consecutive synchronized or unsynchronized shocks can be delivered by the device (see Fig. 12-14). Modern ICD batteries have the capacity to deliver over 100 shocks and usually last 5 to 7 years.

Because tachyarrhythmia detection is based on the heart rate, a risk of inappropriate therapies exists for supraventricular tachyarrhythmias with rapid ventricular responses (for example, atrial fibrillation). ICDs use sophisticated algorithms to discriminate VT from supraventricular tachycardias (SVTs). However, limited information about arrhythmia mechanism and distinction is obtainable from a single ventricular lead, so that unwanted shocks due to SVT occur in approximately 15% of patients.

Recognizing Pacemaker and ICD Malfunction

Pacemakers are very reliable devices and pacemaker malfunctions are rare, especially after the acute postimplant phase. The commonly encountered problems are: failure to capture, failure to sense, and failure to pace.

Failure to capture is characterized by appropriately timed pacing spikes that are not followed by electrical activity of the heart (Fig. 21-15). The most common causes are lead dislodgment, leakage in the pacing circuit, inappropriately set pacing outputs, and rise in pacing threshold due to ischemia, fibrosis, or electrolyte abnormalities (e.g., hyperkalemia).

Failure to sense (see Fig. 21-15) is characterized by excessive and inappropriately timed pacing activity. It can be due to lead dislodgment, inappropriately set sensitivity, or changes in intrinsic signal amplitude due to ischemia, electrolyte abnormalities, or fibrosis.

Failure to pace (Fig. 21-16) is usually due to the pacemaker inhibition by noncardiac electrical signals, such as from skeletal muscle, the diaphragm, external electromagnetic sources (electrocautery, lithotripsy, MRI machines), or electrical interference (“noise”) created by fractured pacemaker leads.

ICDs are much more complex devices and their malfunctions occur more often than with pacemakers. In addition to the pacing malfunctions similar to those described previously, the most important tachyarrhythmia malfunctions include inappropriate therapies (ATP and shocks) for SVT or for oversensing of extracardiac electrical activity (from fractured leads or electromagnetic interference). Inappropriate shocks can be very painful and lead to emotional distress.

Once a device malfunction is suspected, a magnet can be applied over the generator if indicated for emergency management, and a full device interrogation needs to be performed by qualified personnel.

Magnet Response of Pacemakers and ICDs

Programming and interrogation of pacemakers and ICDs requires vendor-specific equipment. However, pacemakers and ICD also respond to magnet application.

The response of pacemakers to magnet application is different from that of ICDs.

Magnet application over the pacemaker generator header (top area where the lead exits) switches most pacemakers to an “asynchronous” mode (DDD → DOO; VVI → VOO) at a preset magnet rate (Fig. 21-17), which varies between manufacturers and indicates the battery status. As the battery is depleted, the magnet rate usually slows.

Thus, the magnet application provides key information about the following “troubleshooting” questions for evaluating an electronic pacemaker:

The magnet response persists as long as the magnet remains close to the generator device header. In contrast, magnet application over an ICD header does not change its pacing mode. Instead, the magnet mode, by design, disables arrhythmia detection. This response is useful, for example, to prevent further shocks in a patient receiving multiple inappropriate shocks for atrial fibrillation with a rapid ventricular response or because of ICD lead fracture. Of course, while the device is disabled, the patient has to be continuously monitored.

Pacemaker and ICD Implantation: Specific Indications

Specific clinical indications for device implantation are subject to review and updates (see current ACC/AHA/HRS recommendations at their websites).

In general, pacing is indicated in three major settings:

ICD implantation is indicated for secondary and primary prevention of sudden cardiac death due to ventricular tachyarrhythmias. Note: Secondary prevention refers to therapy of patients who have already survived an episode of life-threatening ventricular arrhythmia and, therefore, are at high risk of its recurrence. They include the following:

Primary prevention refers to prophylactic ICD implantation in patients who have never had cardiac arrest or documented ventricular arrhythmias but are thought to be at high risk for it. They include patients with structural heart disease (very low left ventricular ejection fraction) and chronic heart failure.